A delta-4 C19 steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as a precursor to testosterone as well as estrone and estradiol.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Flunisolide | The risk or severity of edema formation can be increased when Androstenedione is combined with Flunisolide. |
| Beclomethasone dipropionate | The risk or severity of edema formation can be increased when Androstenedione is combined with Beclomethasone dipropionate. |
| Betamethasone | The risk or severity of edema formation can be increased when Androstenedione is combined with Betamethasone. |
| Fluticasone propionate | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluticasone propionate. |
| Fluocinolone acetonide | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluocinolone acetonide. |
| Triamcinolone | The risk or severity of edema formation can be increased when Androstenedione is combined with Triamcinolone. |
| Prednisone | The risk or severity of edema formation can be increased when Androstenedione is combined with Prednisone. |
| Fludrocortisone | The risk or severity of edema formation can be increased when Androstenedione is combined with Fludrocortisone. |
| Hydrocortisone | The risk or severity of edema formation can be increased when Androstenedione is combined with Hydrocortisone. |
| Prednisolone | The risk or severity of edema formation can be increased when Androstenedione is combined with Prednisolone. |
| Methylprednisolone | The risk or severity of edema formation can be increased when Androstenedione is combined with Methylprednisolone. |
| Trilostane | The risk or severity of edema formation can be increased when Androstenedione is combined with Trilostane. |
| Corticotropin | The risk or severity of edema formation can be increased when Androstenedione is combined with Corticotropin. |
| Cortisone acetate | The risk or severity of edema formation can be increased when Androstenedione is combined with Cortisone acetate. |
| Paramethasone | The risk or severity of edema formation can be increased when Androstenedione is combined with Paramethasone. |
| Ciclesonide | The risk or severity of edema formation can be increased when Androstenedione is combined with Ciclesonide. |
| Aldosterone | The risk or severity of edema formation can be increased when Androstenedione is combined with Aldosterone. |
| Fluticasone furoate | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluticasone furoate. |
| Fluprednidene | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluprednidene. |
| Tixocortol | The risk or severity of edema formation can be increased when Androstenedione is combined with Tixocortol. |
| Fluprednisolone | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluprednisolone. |
| Meprednisone | The risk or severity of edema formation can be increased when Androstenedione is combined with Meprednisone. |
| Dexamethasone isonicotinate | The risk or severity of edema formation can be increased when Androstenedione is combined with Dexamethasone isonicotinate. |
| Melengestrol | The risk or severity of edema formation can be increased when Androstenedione is combined with Melengestrol. |
| Deflazacort | The risk or severity of edema formation can be increased when Androstenedione is combined with Deflazacort. |
| Cortivazol | The risk or severity of edema formation can be increased when Androstenedione is combined with Cortivazol. |
| Prednylidene | The risk or severity of edema formation can be increased when Androstenedione is combined with Prednylidene. |
| Fluocortin | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluocortin. |
| Fluperolone | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluperolone. |
| Cloprednol | The risk or severity of edema formation can be increased when Androstenedione is combined with Cloprednol. |
| Fluclorolone | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluclorolone. |
| Fluticasone | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluticasone. |
| Mometasone furoate | The risk or severity of edema formation can be increased when Androstenedione is combined with Mometasone furoate. |
| Hydrocortisone acetate | The risk or severity of edema formation can be increased when Androstenedione is combined with Hydrocortisone acetate. |
| Hydrocortisone cypionate | The risk or severity of edema formation can be increased when Androstenedione is combined with Hydrocortisone cypionate. |
| Hydrocortisone succinate | The risk or severity of edema formation can be increased when Androstenedione is combined with Hydrocortisone succinate. |
| Prednisolone phosphate | The risk or severity of edema formation can be increased when Androstenedione is combined with Prednisolone phosphate. |
| Prednisolone hemisuccinate | The risk or severity of edema formation can be increased when Androstenedione is combined with Prednisolone hemisuccinate. |
| Methylprednisolone hemisuccinate | The risk or severity of edema formation can be increased when Androstenedione is combined with Methylprednisolone hemisuccinate. |
| Prednisone acetate | The risk or severity of edema formation can be increased when Androstenedione is combined with Prednisone acetate. |
| Clocortolone acetate | The risk or severity of edema formation can be increased when Androstenedione is combined with Clocortolone acetate. |
| Melengestrol acetate | The risk or severity of edema formation can be increased when Androstenedione is combined with Melengestrol acetate. |
| Betamethasone phosphate | The risk or severity of edema formation can be increased when Androstenedione is combined with Betamethasone phosphate. |
| Cortisone | The risk or severity of edema formation can be increased when Androstenedione is combined with Cortisone. |
| Dexamethasone | The risk or severity of edema formation can be increased when Androstenedione is combined with Dexamethasone. |
| Budesonide | The risk or severity of edema formation can be increased when Androstenedione is combined with Budesonide. |
| Clobetasol propionate | The risk or severity of edema formation can be increased when Androstenedione is combined with Clobetasol propionate. |
| Fluocinonide | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluocinonide. |
| Hydrocortisone butyrate | The risk or severity of edema formation can be increased when Androstenedione is combined with Hydrocortisone butyrate. |
| Desoximetasone | The risk or severity of edema formation can be increased when Androstenedione is combined with Desoximetasone. |
| Mometasone | The risk or severity of edema formation can be increased when Androstenedione is combined with Mometasone. |
| Fluocortolone | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluocortolone. |
| Prednisolone acetate | The risk or severity of edema formation can be increased when Androstenedione is combined with Prednisolone acetate. |
| Fluorometholone | The risk or severity of edema formation can be increased when Androstenedione is combined with Fluorometholone. |
| Difluocortolone | The risk or severity of edema formation can be increased when Androstenedione is combined with Difluocortolone. |
| Flumethasone | The risk or severity of edema formation can be increased when Androstenedione is combined with Flumethasone. |
| Methylprednisolone aceponate | The risk or severity of edema formation can be increased when Androstenedione is combined with Methylprednisolone aceponate. |
| Pitolisant | The serum concentration of Androstenedione can be decreased when it is combined with Pitolisant. |
| Metreleptin | The metabolism of Androstenedione can be increased when combined with Metreleptin. |
| Cenobamate | The serum concentration of Androstenedione can be decreased when it is combined with Cenobamate. |
| Ritonavir | The serum concentration of Androstenedione can be increased when it is combined with Ritonavir. |
| Haloperidol | The serum concentration of Haloperidol can be increased when it is combined with Androstenedione. |
| Tucatinib | The metabolism of Tucatinib can be decreased when combined with Androstenedione. |
| Abametapir | The serum concentration of Androstenedione can be increased when it is combined with Abametapir. |
| Satralizumab | The serum concentration of Androstenedione can be decreased when it is combined with Satralizumab. |
| Sotorasib | The serum concentration of Androstenedione can be decreased when it is combined with Sotorasib. |
| Cyclosporine | The metabolism of Androstenedione can be decreased when combined with Cyclosporine. |
| Fluvoxamine | The metabolism of Androstenedione can be decreased when combined with Fluvoxamine. |
| Fluconazole | The metabolism of Androstenedione can be decreased when combined with Fluconazole. |
| Erythromycin | The serum concentration of Androstenedione can be increased when it is combined with Erythromycin. |
| Ziprasidone | The metabolism of Androstenedione can be decreased when combined with Ziprasidone. |
| Isradipine | The metabolism of Androstenedione can be decreased when combined with Isradipine. |
| Diltiazem | The metabolism of Androstenedione can be decreased when combined with Diltiazem. |
| Clozapine | The metabolism of Androstenedione can be decreased when combined with Clozapine. |
| Ciprofloxacin | The metabolism of Androstenedione can be decreased when combined with Ciprofloxacin. |
| Nicardipine | The metabolism of Androstenedione can be decreased when combined with Nicardipine. |
| Verapamil | The metabolism of Androstenedione can be decreased when combined with Verapamil. |
| Aprepitant | The metabolism of Androstenedione can be decreased when combined with Aprepitant. |
| Isoniazid | The metabolism of Androstenedione can be decreased when combined with Isoniazid. |
| Primaquine | The metabolism of Androstenedione can be decreased when combined with Primaquine. |
| Miconazole | The metabolism of Androstenedione can be decreased when combined with Miconazole. |
| Fusidic acid | The metabolism of Androstenedione can be decreased when combined with Fusidic acid. |
| Zimelidine | The metabolism of Androstenedione can be decreased when combined with Zimelidine. |
| Dronedarone | The metabolism of Androstenedione can be decreased when combined with Dronedarone. |
| Milnacipran | The metabolism of Androstenedione can be decreased when combined with Milnacipran. |
| Simeprevir | The metabolism of Androstenedione can be decreased when combined with Simeprevir. |
| Isavuconazonium | The metabolism of Androstenedione can be decreased when combined with Isavuconazonium. |
| Desvenlafaxine | The metabolism of Androstenedione can be decreased when combined with Desvenlafaxine. |
| Nilvadipine | The metabolism of Androstenedione can be decreased when combined with Nilvadipine. |
| Seproxetine | The metabolism of Androstenedione can be decreased when combined with Seproxetine. |
| Linagliptin | The metabolism of Androstenedione can be decreased when combined with Linagliptin. |
| Indalpine | The metabolism of Androstenedione can be decreased when combined with Indalpine. |
| Netupitant | The metabolism of Androstenedione can be decreased when combined with Netupitant. |
| Barnidipine | The metabolism of Androstenedione can be decreased when combined with Barnidipine. |
| Benidipine | The metabolism of Androstenedione can be decreased when combined with Benidipine. |
| Venetoclax | The metabolism of Androstenedione can be decreased when combined with Venetoclax. |
| Isavuconazole | The metabolism of Androstenedione can be decreased when combined with Isavuconazole. |
| Fosnetupitant | The metabolism of Androstenedione can be decreased when combined with Fosnetupitant. |
| Berotralstat | The metabolism of Androstenedione can be decreased when combined with Berotralstat. |
| Midostaurin | The metabolism of Androstenedione can be decreased when combined with Midostaurin. |